Results 251 to 260 of about 108,551 (297)

The Maintenance of Dysmyelinated Small‐Diameter Axons by 14‐3‐3s in the Central Nervous System

open access: yesGlia, Volume 74, Issue 11, November 2026.
Dysmyelinated small‐diameter axons are maintained in teneurin‐4 deficient mice at the age of 1 year, while axonal damage is observed. 14‐3‐3s are highly expressed and suppress the progression of the damage in these axons. ABSTRACT In the central nervous system, myelin formed around nerve axons by oligodendrocyte enables efficient conduction of action ...
Nanako Yamada   +15 more
wiley   +1 more source

Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia. [PDF]

open access: yesClin Cancer Res
Yoshimura S   +18 more
europepmc   +1 more source

Diversified cell origin of Helicobacter pylori eradication-responsive gastric diffuse large B-cell lymphomas. [PDF]

open access: yesJ Pathol
Kuo SH   +10 more
europepmc   +1 more source

BCL2: A promising cancer therapeutic target

open access: yesBiochimica Et Biophysica Acta: Reviews on Cancer, 2017
A remarkable characteristic of majority of cancer cells is that, they fail to undergo apoptosis, which in turn confers them a survival advantage over normal cells. Targeted cancer therapy aims at disrupting the functions of proteins that play an important role during cancer progression.
Sathees Chukkurumbal Raghavan
exaly   +5 more sources

Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction

open access: yesBiochemical Pharmacology, 2017
Apoptosis is a highly regulated pathway of programmed cell death relying on the fine balance between pro and antiapoptotic binding partners. Overexpression of the antiapoptotic protein BCL2 in several cancers makes it an ideal target for chemotherapy, with minimum side effects.
Supriya V, Vartak   +11 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy